RAF1
Showing 1 - 25 of 372
Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)
Recruiting
- Cancer
- +6 more
-
Indianapolis, IndianaIndiana University Hospital / IU Simon Cancer Center
Jan 12, 2023
Solid Tumor, B-Raf Mutation-Related Tumors Trial in Australia, United States (BGB-3245)
Recruiting
- Solid Tumor
- B-Raf Mutation-Related Tumors
-
Boston, Massachusetts
- +4 more
Oct 25, 2022
Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)
Recruiting
- Metastatic Uveal Melanoma
- Defactinib Hydrochloride
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023
Solid Tumor, Adult Trial in Australia, United States (Lifirafenib, mirdametinib)
Recruiting
- Solid Tumor, Adult
-
Santa Monica, California
- +5 more
Feb 22, 2022
Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)
Recruiting
- Low-grade Glioma
- Advanced Solid Tumor
-
San Francisco, California
- +35 more
May 25, 2022
Advanced Solid Tumors Trial in Worldwide (MEK162 + RAF265)
Completed
- Advanced Solid Tumors
- MEK162 + RAF265
-
Tampa, Florida
- +7 more
Sep 28, 2020
Pancreatic Adenocarcinoma, Lung Cancer Trial in Truro (Biocartis Idylla platform - real time PCR detecting EGFR, KRAS and BRAF
Unknown status
- Pancreatic Adenocarcinoma
- Lung Cancer
- Biocartis Idylla platform - real time PCR detecting EGFR, KRAS and BRAF mutations in liquid based cytology and blood plasma samples
-
Truro, Cornwall, United KingdomRoyal Cornwall Hospital
Feb 26, 2021
Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)
Recruiting
- Low Grade Ovarian Serous Adenocarcinoma
- Ovarian Cancer
- avutometinib (VS-6766)
- avutometinib (VS-6766) and Defactinib
-
Scottsdale, Arizona
- +46 more
Dec 29, 2022
Blastic Phase, Childhood Acute Promyelocytic Leukemia With PML-RARA, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Completed
- Blastic Phase
- +9 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +24 more
Jan 13, 2021
Neurofibromatosis Type I, Plexiform Neurofibroma Trial in Birmingham, Bethesda (Nexavar (BAY 43-9006) (Sorafenib), Toxicity,
Completed
- Neurofibromatosis Type I
- Plexiform Neurofibroma
- Nexavar (BAY 43-9006) (Sorafenib)
- +5 more
-
Birmingham, Alabama
- +1 more
Dec 11, 2019
Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Locally Advanced Malignant Solid Neoplasm
- Binimetinib
- +22 more
- (no location specified)
Dec 2, 2022
Forensic Outpatient Systemic Therapy:Multiple Case Experimental
Recruiting
- Conduct Disorder
- +3 more
- FAST
-
Utrecht, Netherlands
- +1 more
Sep 4, 2023
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Conduct Disorder, Antisocial Behavior, Behavioral Disorder Trial in Utrecht (FASTb, FASTr)
Recruiting
- Conduct Disorder
- +2 more
- FASTb
- FASTr
-
Utrecht, Netherlands
- +1 more
Jan 17, 2023
Gastro Intestinal Bleeding, Polyps Trial in Belgium, Netherlands (NEXPOWDER-ENDOHS)
Recruiting
- Gastro Intestinal Bleeding
- Polyps
- NEXPOWDER-ENDOHS
-
Gent, Oost-Vlaanderen, Belgium
- +11 more
Oct 20, 2023
Hypoxia Trial in Genk (Arterial blood draw, Oxygen reduction)
Recruiting
- Hypoxia
- Arterial blood draw
- Oxygen reduction
-
Genk, BelgiumHypoxia Centre of the Complementary Medical Centre (CMC)
Mar 16, 2023
Epidermolysis Bullosa Dystrophica, Squamous Cell Carcinoma Trial in Salzburg (Rigosertib Oral Capsules / Rigosertib Intravenous)
Recruiting
- Epidermolysis Bullosa Dystrophica
- Squamous Cell Carcinoma
- Rigosertib Oral Capsules / Rigosertib Intravenous
-
Salzburg, AustriaEB House Austria/Dept. of Dermatology University Hospital
Nov 3, 2022
Evaporative Dry Eye Trial in Valencia (Preservative free hyaluronic acid artificial tear)
Completed
- Evaporative Dry Eye
- Preservative free hyaluronic acid artificial tear
-
Valencia, SpainDreamhack Convention
Sep 9, 2022
Solid Tumours, Multiple Myeloma, Lung Cancer Trial in Sutton, London (VS-6766, Everolimus)
Recruiting
- Solid Tumours
- +2 more
-
Sutton, Surrey, United Kingdom
- +1 more
Apr 25, 2022
Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive
Not yet recruiting
- Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
- Non-investigational
- (no location specified)
May 11, 2023
NSCLC, Low Grade Serous Ovarian Cancer, Endometrioid Carcinoma Trial in United Kingdom (VS-6766, Defactinib)
Recruiting
- NSCLC
- +3 more
-
Manchester, Greater Manchester, United Kingdom
- +4 more
Mar 18, 2022